The roles of cytochrome b5 in cytochrome P450 reactions

Journal of Biochemical and Molecular Toxicology

Volumn 16, Issue 6, 2002, Pages 311-316

  Porter, Todd D ^a  

^a University of Kentucky   (United States)

Author keywords

Cytochrome b5; Cytochrome b5 reductase; Cytochrome P450; Cytochrome P450 reductase; Electron transfer

Indexed keywords

17 HYDROXYPREGNENOLONE; ACETANILIDE; ANDROSTENEDIONE; ANILINE; CHLORZOXAZONE; COUMARIN; CYCLOSPORIN; CYTOCHROME B5; CYTOCHROME P450; DICLOFENAC; ETHOXYCOUMARIN; GLUCOCORTICOID; HEMOPROTEIN; HYDROXYPROGESTERONE; LAURIC ACID; MEPHENYTOIN; MIDAZOLAM; MYRISTIC ACID; NICOTINE; NIFEDIPINE; OMEPRAZOLE; PACLITAXEL; QUINIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TESTOSTERONE; TOLBUTAMIDE; TROGLITAZONE; UNINDEXED DRUG; UNSPECIFIC MONOOXYGENASE; WARFARIN; CYTOCHROME B5 REDUCTASE; CYTOCHROME REDUCTASE; FERROUS ION; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SEX HORMONE;

ALLOSTERISM; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG OXIDATION; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME MECHANISM; EUKARYOTIC CELL; HUMAN; IN VIVO STUDY; NONHUMAN; REVIEW; ANIMAL; BIOSYNTHESIS; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

EUKARYOTA;

ALLOSTERIC REGULATION; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROME REDUCTASES; CYTOCHROME-B(5) REDUCTASE; CYTOCHROMES B5; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM; FERROUS COMPOUNDS; GLUCOCORTICOIDS; GONADAL STEROID HORMONES; HUMANS; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDATION-REDUCTION;

EID: 0036947946     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.10052     Document Type: Review

References (45)

1. 5 in hepatic microsomal mixed-function oxidation reactions. Arch Biochem Biophys 1971;143:66-79.
2. 5, its functions, structure and membrane topology. Biochimie 1995;77:604-620.
3. Conney AH, Brown RR, Miller JA, Miller EC. The metabolism of methylated aminoazo dyes. VI. Intracellular distribution and properties of the demethylase system. Cancer Res 1957;17:628-633.
4. Correia MA, Mannering GJ. DPNH synergism of TPNH-dependent mixed function oxidase reactions. Drug Metab Dispos 1973;1:139-149.
5. 5 in the NADH synergism of the NADPH-dependent monooxidase system of hepatic microsomes. Biochem Biophys Res Commun 1974;57:476-481.
6. 5 in drug oxidation reactions of mouse liver microsomes. Biochem Biophys Res Commun 1979;91:207-213.
7. 5 in fatty acid desaturation by rat liver microsomes. J Biochem (Tokyo) 1971;69:155-167.
8. 5 reduction by NADPH-cytochrome P-450 reductase. J Biol Chem 1979;254:8976-8981.
9. Taniguchi H, Imai Y, Sato R. Role of the electron transfer system in microsomal drug monooxygenase reaction catalyzed by cytochrome P-450. Arch Biochem Biophys 1984;232:-985-996.
10. Kuwahara S, Mannering GJ. Evidence for a predominantly NADH-dependent O-dealkylating system in rat hepatic microsomes. Biochem Pharmacol 1985;34:4215-4228.
11. 5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch Biochem Biophys 1996;325:174-182.
12. 5. J Biol Chem 1996;271:27438-27444.
13. 5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem Pharmacol 1996;52:301-309.
14. 5 coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium. Mutat Res 2001;484:61-68.
15. Cooper MT, Porter TD. Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase. Mutat Res 2000;454:45-52.
16. Shen AL, O'Leary KA, Kasper CB. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem 2002;277:6536-6541.
17. Sutter TR, Loper JC. Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole. Biochem Biophys Res Commun 1989;160:1257-1266.
18. 5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction. FEBS Lett 1999;462:283-288.
19. 5 in hydroxylation by a reconstituted cytochrome P-450-containing system. J Biol Chem 1974;249:6701-6709.
20. Guengerich FP. Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome p-450 reductase related to catalysis in reconstituted systems. Biochemistry 1983;22:2811-2820.
21. 5 of hydroxylase activities in mouse 2A P450S. Biochemistry 1992;31:11519-11523.
22. 5 on Xenobiotic Oxidations Catalyzed by 12 Recombinant Human Cytochrome P450s Expressed in Membranes of Escherichia coli. Protein Expr Purif 2002;24:329-337.
23. 5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proc Natl Acad Sci USA 1990;87:5425-5429.
24. 5 from rabbit liver. Proc Natl Acad Sci USA 1987;84:11-15.
25. 5. Drug Metab Dispos 1984;12:358-364.
26. Yamazaki H, Gillam EM, Dong MS, Johnson WW, Guengerich FP, Shimada T. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: Effects of cytochrome P450-P450 and cytochrome P45045 interactions. Arch Biochem Biophys 1997;342:329-337.
27. 5. J Biol Chem 1985;260:4007-4015.
28. 5 rules uncoupling mechanisms. Biochemistry 1998;37:11412-11424.
29. 5 effects vary with substrate. Arch Biochem Biophys 2001;385:311-321.
30. 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 1998;273:3158-3165.
31. 5. Arch Biochem Biophys 2001;395:78-84.
32. 5 heme propionate groups. Arch Biochem Biophys 1986;245:512-522.
33. 5 to the oxyferrous intermediate of liver microsomal cytochrome P-450 LM2. J Biol Chem 1981;256:9457-9465.
34. 5 in the process. Arch Biochem Biophys 1994;314:234-241.
35. Guengerich FP, Johnson WW. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: Rapid reduction in the absence of substrate and variations among cytochrome P450 systems. Biochemistry 1997;36:14741-14750.
36. 5 and cytochrome P450 reductase. J Biol Chem 1998;273:17036-17049.
37. 5. Drug Metab Rev 1999;31:351-364.
38. 5 with cytochromes P4503A4 and P45017A: Relevance of heme transfer reactions. Biochemistry 2001;40:5018-5031.
39. 5 or heme oxygenase. J Biol Chem 2001;276:30885-30891.
40. Pompon D, Perret A, Bellamine A, Laine R, Gautier JC, Urban P. Genetically engineered yeast cells and their applications. Toxicol Lett 1995;82/83:815-822.
41. 5 on CYP3A4 activity and stability in vivo. Arch Biochem Biophys 1999;366:116-124.
42. Mason JI, Estabrook RW, Purvis JL. Testicular cytochrome P-450 and iron-sulfur protein as related to steroid metabolism. Ann NY Acad Sci 1973;212:406-419.
43. 5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing's syndrome. Endocrinol J 1998;45:89-95.
44. Brock BJ, Waterman MR. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry 1999;38:1598-1606.
45. 5. Mol Endocrinol 1999; 13: 167-175.